Webinar | April 21, 2020

Are You Really Ready For Your End Of Phase 2 (EOP2) Meeting?

Source: Rho

The end-of-phase 2 (EOP2) meeting with FDA is a critical milestone in your development program and likely the most important interaction you will have with the Agency. Getting the most from this meeting can help successfully launch your phase 3 program and help you begin preparing for your marketing application (NDA/BLA) submission. This webinar will cover:

  • Goals for your EOP2 meeting
  • What does it mean to be phase 3 ready?
  • Developing the right questions to obtain clarity from FDA
  • Timing considerations
  • Common themes in FDA feedback Companies nearing completion of their phase 2 studies or who are planning phase 3 programs will benefit from this webinar.

 

VIEW THE WEBINAR!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Clinical Leader? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: